Latitude patient management system

Manufactured by Boston Scientific

Sourced in United States

The LATITUDE Patient Management System is a medical device used to monitor and manage implanted cardiac devices, such as pacemakers and defibrillators. It enables remote communication between healthcare providers and patients with these implanted devices.

Automatically generated - may contain errors

Lab products found in correlation

Carelink network, by Medtronic (2 mentions) Merlin net, by Abbott (1 mentions) Home monitoring, by Biotronik (1 mentions)

4 protocols using latitude patient management system

Cardiac Device Shock Analysis and Appropriateness

Check if the same lab product or an alternative is used in the 5 most similar protocols

Demographic and clinical data were submitted to a central database. Data included age, sex, baseline heart disease, body mass index (BMI), history of ventricular tachycardia (VT) and/or ventricular fibrillation (VF), previous cardiac implantable electronic device infection, left ventricular ejection fraction, atrial fibrillation, and procedural characteristics. After device implantation, follow-up visits at the device clinic were scheduled for every 1–3 months, and device-related data were collected at those visits. All patients used a remote monitoring system (LATITUDE Patient Management System; Boston Scientific). Shock data are collected from the remote monitoring system by automatic monthly transmission. Device-related data also are collected during unplanned visits to an outpatient clinic or hospital for device shocks.
All shocks were analyzed by at least 2 investigators, who were blinded to the results of TET and classified by consensus. Shocks were classified as appropriate if they were due to a ventricular tachyarrhythmia. IASs were subclassified by the presence of MPI. The incidence of MPI by TET and the relationship between the results of TET and IAS due to MPI were assessed.

Ishida Y., Sasaki S., Toyama Y., Nishizaki K., Shoji Y., Kinjo T., Itoh T., Horiuchi D., Kimura M., Gold M.R, & Tomita H. (2020). A novel screening test for inappropriate shocks due to myopotentials from the subcutaneous implantable cardioverter–defibrillator. Heart Rhythm O2, 1(1), 27-34.

+ Open protocol

+ Expand

Remote Monitoring of Cardiac Implantable Devices

Check if the same lab product or an alternative is used in the 5 most similar protocols

Between January 2010 and December 2012, patients with a CIED were recommended to undergo remote monitoring at the discretion of the attending cardiologists. Since January 2013, all patients who underwent CIED-related procedures were routinely recommended for the implementation of remote monitoring. In the remote monitoring systems provided by three venders (Home Monitoring™, Biotronik; Latitude Patient Management system™, Boston Scientific, and Merlin.net™, Abbott) the records were automatically transmitted to our institution once a week via home transmitters. In the system from the fourth vendor (CareLink Network™, Medtronic, Inc.), data from the patients with a pacemaker were transmitted once a month, whereas data from patients with an implantable cardioverter defibrillator and cardiac resynchronization therapy were transmitted once a week. The data were reviewed by experienced clinical engineers and electrophysiologists once a week. When unscheduled transmissions were obtained, the data were quickly reviewed. Inquiry for patients was performed by physicians when the scheduled transmission was missed for a week.

Ishiguchi H., Yoshiga Y., Shimizu A., Ueyama T., Ono M., Fukuda M., Kato T., Fujii S., Hisaoka M., Uchida T., Omuro T., Okamura T., Kobayashi S, & Yano M. (2022). The Differential Prognostic Impact of Long-Duration Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices between Patients with and without a History of Atrial Fibrillation. Journal of Clinical Medicine, 11(6), 1732.

+ Open protocol

+ Expand

Remote Monitoring of Cardiac Implants

Check if the same lab product or an alternative is used in the 5 most similar protocols

RM systems included both wireless RM (WRM) and manual RM devices. WRM devices enable the automatic transmissions of daily or weekly alerts, whereas manual RM devices require that patients manually interrogate the PM/ICD with the handle of the gateway. Centers involved in the study used a similar organizational model to provide telemedicine services. Figure 1 shows the workflow for managing RM of PM/ICD patients.
The process consists of the following six steps:
All involved nurses and physicians had specific competence in cardiac electrophysiology and electro-stimulation. They were also exposed to a specific training offered by vendors’ specialists regarding the use of RM technology and portals. The training consisted of a face-to-face session lasting one hour. RM systems [17 (link)] were supplied by one of the five following Companies: (1) HM of Biotronik Gmbh, Berlin, German; (2) CareLink Network by Medtronic Inc, Minneapolis, MN, USA; (3) Latitude Patient Management System by Boston Scientific, St Paul, MN, USA; (4) Merlin.Net system by St Jude Medical, Sylmar, CA, USA; and (5) SmartView system by Sorin Group, Italy.

Dario C., Delise P., Gubian L., Saccavini C., Brandolino G, & Mancin S. (2016). Large Controlled Observational Study on Remote Monitoring of Pacemakers and Implantable Cardiac Defibrillators: A Clinical, Economic, and Organizational Evaluation. Interactive Journal of Medical Research, 5(1), e4.

+ Open protocol

+ Expand

ICD/CRT-D Implantation Eligibility

Check if the same lab product or an alternative is used in the 5 most similar protocols

Consecutive patients receiving an ICD or CRT-defibrillator (CRT-D) at one of the participating centres will be screened for study participation. Patients implanted with a first-time (primary or secondary prophylactic) ICD or CRT-D compatible with the LATITUDE® Patient Management system from Boston Scientific, with left ventricular ejection fraction ≤35 % and symptomatic heart failure (New York Heart Association functional class II or III) at the time of implantation, and providing written informed consent will be eligible to participate. Patients will be excluded if they are younger than 18 or older than 85 years of age, on the waiting list for heart transplantation, have a history of psychiatric illness other than affective/anxiety disorders, or are unable to complete the questionnaires due to cognitive impairments or insufficient knowledge of the language.

Versteeg H., Pedersen S.S., Mastenbroek M.H., Redekop W.K., Schwab J.O., Mabo P, & Meine M. (2014). Patient perspective on remote monitoring of cardiovascular implantable electronic devices: rationale and design of the REMOTE-CIED study. Netherlands Heart Journal, 22(10), 423-428.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!